TTRX

Conviction 70HealthcareScan · Mon, Aug 10, 2026

TTRX$9.57-8.07%

ResistanceSupportVol 14

Vol MA14 60.52K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Turn Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.turntherapeutics.com ↗

Price9.57

Change-8.07%

Gap-1.44%

Rel volume0.26×

Avg volume78.82K

Avg $ vol730.29K

SMA 209.11

SMA 507.67

SMA 2004.80

Price vs 50+24.76%

Price vs 200+99.26%

MA stackbullish

50/200 cross—

Supertrendup · 7.40

RSI (14)58

MACD hist0.03

MACD crossbull · 1d

Stoch %K / %D70 / 80

ADX (14)30

+DI / −DI30 / 17

RSI divergenceBearish

MACD divergenceBearish

ATR %+9.31%

ADR %9.33%

52w high10.41

52w low2.71

From 52w high-8.07%

Above 52w low+253.14%

New 52w highNo

SqueezeOff

Bollinger width36.27%

%B0.64

Donchian pos70.22%

Donchian high10.59

Donchian low7.17

AVWAP (52w high)10.58

vs AVWAP high-9.55%

AVWAP (52w low)5.85

vs AVWAP low+63.61%

OBV trendUp

Chaikin MF (20)0.00

Today vs 20d0.26×

Avg vol (14d)60.52K

Avg vol (20d)78.82K

Avg $ vol (20d)730.29K

Market cap285.07M

RS 3m (vs SPY)+168.61%

RS 6m (vs SPY)+167.24%

RS line new highNo

Trend template—

Technical rank86.6

1 week+8.26%

1 month+1.38%

3 months+152.51%

6 months+148.57%

1 year—

YTD+104.05%

P/E-89.25

P/B46.60

P/S—

P/FCF—

EPS-0.1200

Div yield—

ROE-52.21%

ROA-17.13%

Debt/Eq0.97

Current2.23

EV/EBITDA-48.23

Gross margin—

Net margin—

Rev growth—

EPS growth-80.62%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value280M

Revenue—

Net income-970.97K

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out29.79M

Employees2

ListedWed, Oct 8, 2025

Free float8.02M

Float %27.2%

Short interest57.73K

Days to cover0.3d

Short volume52.8%

Squeeze score12 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction70 / 100

Pattern quality—

Tech rank86.6 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance11.08

Support6.36

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TTRX

All disclosures →

No recent disclosed trades by Congress in TTRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TTRX · 6 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Dewhurst Martin William Director · Stock option (right to buy) · 2026-06-04	Grant	71.67K	$0	2026-06-04	2026-06-08
GOLDEN ARTHUR F Director · Stock option (right to buy) · 2026-06-04	Grant	89.58K	$0	2026-06-04	2026-06-08
Kester Kent Edward Director · Stock option (right to buy) · 2026-06-04	Grant	83.33K	$0	2026-06-04	2026-06-08
Gengos Andrew Director · Stock option (right to buy) · 2026-06-04	Grant	95K	$0	2026-06-04	2026-06-08
BEB Holdings, LLC 10% owner · Common Stock · 2026-05-28	Gift	300K	$0	2026-05-28	2026-06-01
BEB Holdings, LLC 10% owner · Common Stock · 2026-05-28	Gift	300K	$0	2026-05-28	2026-06-01
Burnam Bradley Evan Chief Executive Officer · Common Stock · 2026-05-28	Gift	300K	$0	2026-05-28	2026-06-01
Burnam Bradley Evan Chief Executive Officer · Common Stock · 2026-05-28	Gift	300K	$0	2026-05-28	2026-06-01

SEC filings

EDGAR filings in TTRX · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.